drugset / Trial / NCT04258761
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this research study is to find out more about an investigational drug, 10XB-101, for people with fat under their chin which they would like to remove. The Sponsor of this study thinks there may be a chance this drug could be used to dissolve, or "melt" this fat away.
Timeline
- Start
- 2019-10-10
- Primary completion
- 2022-06-30
- Completion
- 2022-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Polidocanol | Other / unclassified | 1.25 % | Subcutaneous |
| Subject | Polidocanol | Other / unclassified | 2 % | Subcutaneous |
| Subject | Polidocanol | Other / unclassified | 3 % | Subcutaneous |
| Subject | Polidocanol | Other / unclassified | 4.5 % | Subcutaneous |
| Subject | Polidocanol | Other / unclassified | 6 % | Subcutaneous |
Indications
No indication recorded.